The menu is marketed for guests using GLP-1 agonists to help them achieve their weight loss or weight management goals, the company said in a press release
Clinical Implications for Patient Selection The observed survival advantage implies that sleep apnea may serve as a marker of enhanced responsiveness to GLP-1 therapy in diabetes management
You can check the FDA website for more information
A subset of 532 participants with BMI 35 at baseline who tolerated their assigned dose continued into an extension out to 104 weeks
However, they are likely to be fully out of stock soon, which is why the FDA made the IR formula an official addition to the nationwide shortage list
Medicare GLP-1 Bridge at a Glance Start date: July 1, 2026 Scheduled end date: December 31, 2027 Cost: $50 for a one-month supply when approved Who may qualify: Eligible adults with Medicare Part D who meet the clinical requirements What is required: A prescription and prior authorization submitted by a qualified health care provider Covered purpose: Reducing excess body weight and maintaining weight reduction Important: Having Medicare or receiving a prescription does not guarantee approval What Is the Medicare GLP-1 Bridge